Asterima Pharmaceuticals Private Limited, a active private limited company, was established on 30 April 2016 in Mumbai, Maharashtra, India. Engaging in pharmaceutical retailers & distributors within the trade sector, it holds CIN: U24230MH2016PTC280401. Registered under ROC Roc Mumbai. it is unlisted. It has an authorized capital of ₹1.00 M and a paid-up capital of ₹0.62 M.
It upholds a compliant status. Its leadership includes Mandeep Warrier (Director), Soumya Tomy (Director), Saneesh Methanath (Managing Director). Past directors included Anitha Prabhakaran, Prabhakaran Thottassery Krishnankutty. It holds ₹3.00 M open charges and no settled loans. Its latest AGM occurred on 30 September 2024, with the balance sheet filed on 31 March 2024. It is based at E-309, Third Floor, Crystal Plaza Opp.Infinity Mall, Andheri Link Road, An, Dheri West, Mumbai, Maharashtra, 400053.
U24230MH2016PTC280401
280401
30 April 2016
₹1.00 M
₹0.62 M
Roc Mumbai
Unlisted
Active
Explore comprehensive insights into Asterima Pharmaceuticals Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Mandeep Warrier | Director | 10 Jul 2021 | Current |
| Soumya Tomy | Director | 13 Dec 2022 | Current |
| Saneesh Methanath | Managing Director | 30 Apr 2016 | Current |
| Girish | Director | 01 Oct 2021 | Current |
| Arun | Director | 01 Oct 2021 | Current |
| Diju Thottasseri Prabhakaran | Director | 02 Nov 2020 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Director | 02 Nov 2020 | Past |
| Pramod Abcsdd | Director | 02 Nov 2020 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Asterima Pharmaceuticals Private Limited, for the financial year ended 2019, experienced no change in revenue, with a 0% increase. The company also saw a no change in profitability, with a 0% increase in profit. The company's net worth observed a substantial decline by a decrease of 431.75%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets |
| ||||||
| Profit or Loss | |||||||
| Net Worth |
| ||||||
| EBITDA |
In 2019, Asterima Pharmaceuticals had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
₹3,000,000.00
₹0
| Date | Lender | Amount | Status |
|---|---|---|---|
| 20 Apr 2022 | Dhanlaxmi Bank Limited | ₹3.00 M | Open |
Explore comprehensive loan charge details -
Unlock and access historical data on people associated with Asterima Pharmaceuticals, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Gain comprehensive insights into the Deals and Valuation data of Asterima Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Asterima Pharmaceuticals's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Asterima Pharmaceuticals Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records. was recorded as a recent event.
Asterima Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Mumbai. was recorded as a recent event.
Soumya Tomy was appointed as a Director was appointed as a Director on 13 Dec 2022 & has been associated with this company since 2 years 11 months . was recorded as a recent event.
Progress on A charge with Dhanlaxmi Bank Limited amounted to Rs. 3.00 M with Charge ID 100572713 was registered on 20 Apr 2022. was documented.
Girish was appointed as a Director was appointed as a Director on 01 Oct 2021 & has been associated with this company since 4 years 2 months . was recorded as a recent event.
Arun was appointed as a Director was appointed as a Director on 01 Oct 2021 & has been associated with this company since 4 years 2 months . was recorded as a recent event.
The CIN of Asterima Pharmaceuticals Private Limited is U24230MH2016PTC280401.
Asterima Pharmaceuticals Private Limited is headquartered at E-309, Third Floor, Crystal Plaza Opp.Infinity Mall, Andheri Link Road, An, Dheri West, Mumbai, Maharashtra, 400053.
Asterima Pharmaceuticals Private Limited was incorporated on 30 April 2016.
The current directors of Asterima Pharmaceuticals Private Limited are
The primary industry of Asterima Pharmaceuticals Private Limited is Trade.
Asterima Pharmaceuticals Private Limited is unlisted.
The authorized capital of Asterima Pharmaceuticals Private Limited is ₹1.00 M, and the paid-up capital is ₹0.62 M.
The compliance status of Asterima Pharmaceuticals Private Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX